{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T11:40:30Z","timestamp":1773574830782,"version":"3.50.1"},"reference-count":125,"publisher":"Oxford University Press (OUP)","issue":"13","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01\u2009HL-075633"],"award-info":[{"award-number":["R01\u2009HL-075633"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01\u2009HL-743"],"award-info":[{"award-number":["R01\u2009HL-743"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DE-13686"],"award-info":[{"award-number":["R01 DE-13686"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81102486 and 81273509"],"award-info":[{"award-number":["81102486 and 81273509"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,1]]},"DOI":"10.1093\/cvr\/cvx165","type":"journal-article","created":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T03:30:15Z","timestamp":1502422215000},"page":"1585-1602","source":"Crossref","is-referenced-by-count":27,"title":["A novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administration"],"prefix":"10.1093","volume":"113","author":[{"given":"Chahua","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA;"},{"name":"Department of Cardiology, Second Affiliated Hospital, Nanchang University, Nanchang 330006, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Beenken","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifeng","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Center for Structural Biology, Wenzhou Medical University, Zhejiang 325035, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garrett J.","family":"Gross","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Gang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moosa","family":"Mohammadi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo El J.","family":"Schultz","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,9,7]]},"reference":[{"key":"key\n\t\t\t\t20180328160631_cvx165-B1","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1161\/CIR.0000000000000350","article-title":"Heart disease and stroke statistics-2016 update: A report from the american heart association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd2792","article-title":"The fgf family: Biology, pathophysiology and therapy","volume":"8","author":"Beenken","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B3","doi-asserted-by":"crossref","first-page":"3005.1","DOI":"10.1186\/gb-2001-2-3-reviews3005","article-title":"Fibroblast growth factors","volume":"2","author":"Ornitz","year":"2001","journal-title":"Genome Biol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B4","first-page":"26","article-title":"Biological roles of fibroblast growth factor-2","volume":"18","author":"Bikfalvi","year":"1997","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/bbrc.2000.3696","article-title":"Identification of a novel fibroblast growth factor, fgf-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain","volume":"277","author":"Yamashita","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1677\/erc.0.0070165","article-title":"Fibroblast growth factors, their receptors and signaling","volume":"7","author":"Powers","year":"2000","journal-title":"Endocr Relat Cancer"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.carpath.2006.11.004","article-title":"Cardiovascular protection of nonmitogenic human acidic fibroblast growth factor from oxidative damage in vitro and in vivo","volume":"16","author":"Li","year":"2007","journal-title":"Cardiovasc Pathol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B8","first-page":"517","article-title":"Cardioprotection from ischemia by fibroblast growth factor: Role of inducible nitric oxide synthase","volume":"4","author":"Cuevas","year":"1999","journal-title":"Eur J Med Res"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B9","first-page":"145","article-title":"Fibroblast growth factor cardioprotection against ischemia-reperfusion injury may involve k+ atp channels","volume":"5","author":"Cuevas","year":"2000","journal-title":"Eur J Med Res"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/08977199709002110","article-title":"Protection of rat myocardium by mitogenic and non-mitogenic fibroblast growth factor during post-ischemic reperfusion","volume":"15","author":"Cuevas","year":"1997","journal-title":"Growth Factors"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B11","first-page":"33","article-title":"Protective effects of acidic fibroblast growth factor against cardiac arrhythmias induced by ischemia and reperfusion in rats","volume":"2","author":"Cuevas","year":"1997","journal-title":"Eur J Med Res"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B12","first-page":"139","article-title":"A non-mitogenic form of acidic fibroblast growth factor reduces neutrophil infiltration in rat ischemic reperfused heart","volume":"2","author":"Cuevas","year":"1997","journal-title":"Eur J Med Res"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B13","first-page":"282","article-title":"Serum levels of basic fibroblast growth factor in acute myocardial infarction","volume":"2","author":"Cuevas","year":"1997","journal-title":"Eur J Med Res"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B14","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0008-6363(02)00494-7","article-title":"Angiogenesis-independent cardioprotection in fgf-1 transgenic mice","volume":"55","author":"Buehler","year":"2002","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B15","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacc.2004.05.067","article-title":"Fibroblast growth factor-1 improves cardiac functional recovery and enhances cell survival after ischemia and reperfusion: A fibroblast growth factor receptor, protein kinase c, and tyrosine kinase-dependent mechanism","volume":"44","author":"Palmen","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B16","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIR.0b013e31820f2f3e","article-title":"2011 accf\/aha focused update of the guidelines for the management of patients with unstable angina\/non-st-elevation myocardial infarction (updating the 2007 guideline): A report of the american college of cardiology foundation\/american heart association task force on practice guidelines","volume":"123","author":"Wright","year":"2011","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ccl.2008.07.002","article-title":"Anticoagulants in coronary artery disease","volume":"26","author":"Lee","year":"2008","journal-title":"Cardiol Clin"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B18","doi-asserted-by":"crossref","first-page":"e426","DOI":"10.1161\/CIR.0b013e318212bb8b","article-title":"2011 accf\/aha focused update incorporated into the acc\/aha 2007 guidelines for the management of patients with unstable angina\/non-st-elevation myocardial infarction: A report of the american college of cardiology foundation\/american heart association task force on practice guidelines","volume":"123","author":"Anderson","year":"2011","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B19","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/hrt.2010.204511","article-title":"Early management of unstable angina and non-st-segment elevation myocardial infarction: Summary of nice guidance","volume":"96","author":"Gray","year":"2010","journal-title":"Heart"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B20","doi-asserted-by":"crossref","first-page":"478","DOI":"10.18553\/jmcp.2013.19.6.478","article-title":"Influence of coadministration of antithrombotic medicines, warfarin, and nsaids on heparin safety: Data from a prospective observational study","volume":"19","author":"Pranckeviciene","year":"2013","journal-title":"Jmcp"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0140-6736(11)60876-3","article-title":"Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for st-elevation myocardial infarction: The international randomised open-label atoll trial","volume":"378","author":"Montalescot","year":"2011","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B22","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIR.0b013e318256f1e0","article-title":"2012 accf\/aha focused update of the guideline for the management of patients with unstable angina\/non-st-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): A report of the american college of cardiology foundation\/american heart association task force on practice guidelines","volume":"126","author":"Jneid","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B23","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.sbi.2005.09.002","article-title":"A protein canyon in the fgf-fgf receptor dimer selects from an a la carte menu of heparan sulfate motifs","volume":"15","author":"Mohammadi","year":"2005","journal-title":"Curr Opin Struct Biol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B24","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/0092-8674(94)90032-9","article-title":"Heparin-induced oligomerization of fgf molecules is responsible for fgf receptor dimerization, activation, and cell proliferation","volume":"79","author":"Spivak-Kroizman","year":"1994","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a015958","article-title":"Molecular mechanisms of fibroblast growth factor signaling in physiology and pathology","volume":"5","author":"Belov","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cytogfr.2005.01.008","article-title":"Structural basis for fibroblast growth factor receptor activation","volume":"16","author":"Mohammadi","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1677\/joe.0.1340157","article-title":"Bioavailability: Is this a key event in regulating the actions of peptide growth factors?","volume":"134","author":"Logan","year":"1992","journal-title":"J Endocrinol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B28","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0092-8674(91)90512-W","article-title":"Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor","volume":"64","author":"Yayon","year":"1991","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000087862","article-title":"Combination of enoxaparin and fibroblast growth factor-1 increases myocardial blood flow and capillary density after myocardial infarction in rabbits","volume":"37","author":"Geist","year":"2005","journal-title":"Eur Surg Res"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B30","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/BF01939392","article-title":"Distribution of intravenously administered acidic and basic fibroblast growth factors in the mouse","volume":"46","author":"Hondermarck","year":"1990","journal-title":"Experientia"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B31","doi-asserted-by":"crossref","first-page":"L191","DOI":"10.1152\/ajplung.00284.2003","article-title":"Heparin affects signaling pathways stimulated by fibroblast growth factor-1 and -2 in type ii cells","volume":"287","author":"Newman","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B32","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1021\/bi991895z","article-title":"Potentiation and inhibition of bfgf binding by heparin: A model for regulation of cellular response","volume":"39","author":"Fannon","year":"2000","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B33","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3109\/1061186X.2012.702771","article-title":"Improving the cardio protective effect of afgf in ischemic myocardium with ultrasound-mediated cavitation of heparin modified microbubbles: Preliminary experiment","volume":"20","author":"Zhao","year":"2012","journal-title":"J Drug Target"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B34","first-page":"465","article-title":"Fibroblast growth factor-1 prevents myocardial apoptosis triggered by ischemia reperfusion injury","volume":"2","author":"Cuevas","year":"1997","journal-title":"Eur J Med Res"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B35","doi-asserted-by":"crossref","first-page":"H2157","DOI":"10.1152\/ajpheart.1995.268.5.H2157","article-title":"Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts","volume":"268","author":"Schultz","year":"1995","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B36","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1006\/jmcc.1996.0358","article-title":"The ischemia-selective katp channel antagonist, 5-hydroxydecanoate, blocks ischemic preconditioning in the rat heart","volume":"29","author":"Schultz","year":"1997","journal-title":"J Mol Cell Cardiol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B37","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/01.RES.78.6.1100","article-title":"Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart","volume":"78","author":"Schultz","year":"1996","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.regpep.2011.09.008","article-title":"Pharmacokinetics, tissue distribution, excretion, and antiviral activity of pegylated recombinant human consensus interferon-alpha variant in monkeys, rats and guinea pigs","volume":"173","author":"Cai","year":"2012","journal-title":"Regul Pept"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B39","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/jcp.1041400306","article-title":"Stabilization by heparin of acidic fibroblast growth factor mitogenicity for human endothelial cells in vitro","volume":"140","author":"Mueller","year":"1989","journal-title":"J Cell Physiol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jcp.1041380202","article-title":"Heparin potentiates the action of acidic fibroblast growth factor by prolonging its biological half-life","volume":"138","author":"Damon","year":"1989","journal-title":"J Cell Physiol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/10611860290022679","article-title":"Pharmacokinetics and brain uptake of biotinylated basic fibroblast growth factor conjugated to a blood-brain barrier drug delivery system","volume":"10","author":"Wu","year":"2002","journal-title":"J Drug Target"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B42","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1161\/01.CIR.0000105723.91637.1C","article-title":"Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia","volume":"108","author":"House","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B43","doi-asserted-by":"crossref","first-page":"H1382","DOI":"10.1152\/ajpheart.00613.2012","article-title":"Low molecular weight fibroblast growth factor-2 signals via protein kinase c and myofibrillar proteins to protect against postischemic cardiac dysfunction","volume":"304","author":"Manning","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B44","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.yjmcc.2006.10.005","article-title":"The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: The role of jnk signaling","volume":"42","author":"Liao","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B45","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.yjmcc.2010.01.014","article-title":"The influence of fgf2 high molecular weight (hmw) isoforms in the development of cardiac ischemia-reperfusion injury","volume":"48","author":"Liao","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B46","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jpba.2016.12.024","article-title":"Evaluation of automated wes system as an analytical and characterization tool to support monoclonal antibody drug product development","volume":"139","author":"Wang","year":"2016","journal-title":"J Pharm Biomed Anal"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B47","first-page":"403","article-title":"Fibroblast growth factor protects the kidney against ischemia- reperfusion injury","volume":"4","author":"Cuevas","year":"1999","journal-title":"Eur J Med Res"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B48","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1161\/CIRCULATIONAHA.111.032698","article-title":"New horizons in cardioprotection: Recommendations from the 2010 national heart, lung, and blood institute workshop","volume":"124","author":"Schwartz Longacre","year":"2011","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B49","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000028274","article-title":"N-acetylheparin pretreatment reduces infarct size in the rabbit","volume":"58","author":"Park","year":"1999","journal-title":"Pharmacology"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B50","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0022-3565(24)35004-9","article-title":"Ex vivo reversal of heparin-mediated cardioprotection by heparinase after ischemia and reperfusion","volume":"290","author":"Kilgore","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B51","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/107424849600100305","article-title":"Reduction of myocardial necrosis after glycosaminoglycan administration: Effects of a single intravenous administration of heparin or n-acetylheparin 2\u2009hours before regional ischemia and reperfusion","volume":"1","author":"Gralinski","year":"1996","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B52","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0008-6363(96)88632-9","article-title":"Cardioprotective effects of heparin or n-acetylheparin in an in vivo model of myocardial ischaemic and reperfusion injury","volume":"29","author":"Black","year":"1995","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ydbio.2011.05.004","article-title":"Growth factor-dependent branching of the ureteric bud is modulated by selective 6-o sulfation of heparan sulfate","volume":"356","author":"Shah","year":"2011","journal-title":"Dev Biol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B54","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2174\/138161207781039733","article-title":"Interaction of heparins with fibroblast growth factors: Conformational aspects","volume":"13","author":"Guerrini","year":"2007","journal-title":"Curr Pharm Design"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B55","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/glycob\/2.6.523","article-title":"Heparan sulphate in the binding and activation of basic fibroblast growth factor","volume":"2","author":"Gallagher","year":"1992","journal-title":"Glycobiology"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B56","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1042\/bst0210477","article-title":"Heparan sulphate: Functional role as a modulator of fibroblast growth factor activity","volume":"21","author":"Turnbull","year":"1993","journal-title":"Biochem Soc Trans"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B57","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0969-8051(00)00090-1","article-title":"Imaging tc-99m-labeled fgf-1 targeting in rats","volume":"27","author":"Zinn","year":"2000","journal-title":"Nucl Med Biol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.RES.64.2.227","article-title":"Pharmacokinetics and distribution of heparin-binding growth factor i (endothelial cell growth factor) in the rat","volume":"64","author":"Rosengart","year":"1989","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B59","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ahj.2012.07.021","article-title":"Impact of system delay on infarct size, myocardial salvage index, and left ventricular function in patients with st-segment elevation myocardial infarction","volume":"164","author":"L\u00f8nborg","year":"2012","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B60","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/heartjnl-2016-309658","article-title":"Impact of call-to-balloon time on 30-day mortality in contemporary practice","volume":"103","author":"Varcoe","year":"2017","journal-title":"Heart"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B61","first-page":"385","volume-title":"Textbook of cardiovascular medicine, 2nd edition","author":"Topol","year":"2002"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B62","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.amjcard.2007.01.047","article-title":"Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the emerald trial)","volume":"99","author":"Brodie","year":"2007","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B63","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jcin.2014.01.166","article-title":"Impact of delay to reperfusion on reperfusion success, infarct size, and clinical outcomes in patients with st-segment elevation myocardial infarction: The infuse-ami trial (infuse-anterior myocardial infarction)","volume":"7","author":"Guerchicoff","year":"2014","journal-title":"JACC. Cardiovasc Interventions"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B64","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.cjca.2014.08.021","article-title":"Impact of reperfusion strategy on aborted myocardial infarction: Insights from a large canadian st-elevation myocardial infarction clinical registry","volume":"30","author":"Bainey","year":"2014","journal-title":"Can J Cardiol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B65","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/2048872615610893","article-title":"Prognostic impact of non-compliance with guidelines-recommended times to reperfusion therapy in st-elevation myocardial infarction. The fast-mi 2010 registry","volume":"6","author":"Puymirat","year":"2017","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B66","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1177\/2048872616637038","article-title":"Relationship between treatment delay and type of reperfusion therapy and mechanical complications of acute myocardial infarction","volume":"5","author":"Magalhaes","year":"2016","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B67","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1093\/eurheartj\/ehl094","article-title":"Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: The amistad-2 trial","volume":"27","author":"Kloner","year":"2006","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B68","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(07)61634-1","article-title":"Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (j-wind): Two randomised trials","volume":"370","author":"Kitakaze","year":"2007","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B69","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJMoa071142","article-title":"Effect of cyclosporine on reperfusion injury in acute myocardial infarction","volume":"359","author":"Piot","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B70","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1161\/CIRCULATIONAHA.113.003653","article-title":"Effect of early metoprolol on infarct size in st-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of metoprolol in cardioprotection during an acute myocardial infarction (metocard-cnic) trial","volume":"128","author":"Ibanez","year":"2013","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B71","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1161\/ATVBAHA.113.301586","article-title":"Cardioprotective effects of exenatide in patients with st-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Results of exenatide myocardial protection in revascularization study","volume":"33","author":"Woo","year":"2013","journal-title":"Arteriosclero, Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B72","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0735-1097(99)00418-0","article-title":"Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: Results of a multicenter, randomized, placebo-controlled trial: The acute myocardial infarction study of adenosine (amistad) trial","volume":"34","author":"Mahaffey","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B73","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.jacc.2005.02.061","article-title":"A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (amistad-ii)","volume":"45","author":"Ross","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B74","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/jpet.103.064667","article-title":"Acute aspirin treatment abolishes, whereas acute ibuprofen treatment enhances morphine-induced cardioprotection: Role of 12-lipoxygenase","volume":"310","author":"Gross","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B75","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cytogfr.2005.01.004","article-title":"Fibroblast growth factor\/fibroblast growth factor receptor system in angiogenesis","volume":"16","author":"Presta","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B76","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.2174\/138161207781039689","article-title":"Fibroblast growth factors\/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies","volume":"13","author":"Rusnati","year":"2007","journal-title":"Curr Pharm Design"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B77","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/jsre.2000.5945","article-title":"The cysteine-free fibroblast growth factor 1 mutant induces heparin-independent proliferation of endothelial cells and smooth muscle cells","volume":"92","author":"Xue","year":"2000","journal-title":"J Surgi Res"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B78","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1124\/mol.55.1.74","article-title":"In vivo involvement of heparan sulfate proteoglycan in the bioavailability, internalization, and catabolism of exogenous basic fibroblast growth factor","volume":"55","author":"Colin","year":"1999","journal-title":"Mol Pharmacol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B79","doi-asserted-by":"crossref","first-page":"e48210.","DOI":"10.1371\/journal.pone.0048210","article-title":"Pharmacokinetic properties of 2nd-generation fibroblast growth factor-1 mutants for therapeutic application","volume":"7","author":"Xia","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B80","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/nature05817","article-title":"Heparan sulphate proteoglycans fine-tune mammalian physiology","volume":"446","author":"Bishop","year":"2007","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B81","doi-asserted-by":"crossref","first-page":"25388","DOI":"10.1074\/jbc.M109.001289","article-title":"Increased protein stability of fgf1 can compensate for its reduced affinity for heparin","volume":"284","author":"Zakrzewska","year":"2009","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B82","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jmb.2005.07.066","article-title":"Highly stable mutants of human fibroblast growth factor-1 exhibit prolonged biological action","volume":"352","author":"Zakrzewska","year":"2005","journal-title":"J Mol Biol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B83","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.1021\/bi9927742","article-title":"Thermodynamic characterization of mutants of human fibroblast growth factor 1 with an increased physiological half-life","volume":"39","author":"Culajay","year":"2000","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B84","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/stem.1021","article-title":"Thermal stability of fibroblast growth factor protein is a determinant factor in regulating self-renewal, differentiation, and reprogramming in human pluripotent stem cells","volume":"30","author":"Chen","year":"2012","journal-title":"Stem Cells"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B85","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2174\/0929866520666131203102315","article-title":"Protease resistant variants of fgf1 with prolonged biological activity","volume":"21","author":"Kobielak","year":"2014","journal-title":"Ppl"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-291X(76)90241-2","article-title":"Characteristic distribution of sulfated mucopolysaccharides in different tissues and in their respective mitochondria","volume":"71","author":"Dietrich","year":"1976","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B87","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/01.CIR.100.9.981","article-title":"Effects of chronic heparin administration on coronary vascular adaptation to hypertension and ventricular hypertrophy in sheep","volume":"100","author":"Flanagan","year":"1999","journal-title":"Circulatio"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B88","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijcard.2010.07.024","article-title":"Acidic and basic fibroblast growth factors involved in cardiac angiogenesis following infarction","volume":"152","author":"Zhao","year":"2011","journal-title":"International J Cardiol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B89","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1177\/000331979704801106","article-title":"The coronary angiogenetic effect of heparin: Experimental basis and clinical evidence","volume":"48","author":"Bombardini","year":"1997","journal-title":"Angiology"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B90","doi-asserted-by":"crossref","first-page":"26628","DOI":"10.1074\/jbc.M109.095109","article-title":"Influence of heparin mimetics on assembly of the fgf.Fgfr4 signaling complex","volume":"285","author":"Saxena","year":"2010","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B91","doi-asserted-by":"crossref","first-page":"15292","DOI":"10.1074\/jbc.271.25.15292","article-title":"Receptor specificity of the fibroblast growth factor family","volume":"271","author":"Ornitz","year":"1996","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B92","doi-asserted-by":"crossref","first-page":"17121","DOI":"10.1074\/jbc.M212590200","article-title":"The involvement of heparan sulfate (hs) in fgf1\/hs\/fgfr1 signaling complex","volume":"278","author":"Wu","year":"2003","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B93","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/778","article-title":"New insights into heparin-induced fgf oligomerization","volume":"5","author":"Waksman","year":"1998","journal-title":"Nat Struct Biol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B94","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1126\/science.7536345","article-title":"Fgf binding and fgf receptor activation by synthetic heparan-derived di- and trisaccharides","volume":"268","author":"Ornitz","year":"1995","journal-title":"Science"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B95","doi-asserted-by":"crossref","first-page":"8876","DOI":"10.1021\/bi00152a026","article-title":"Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: A mechanism for cooperactivity","volume":"31","author":"Nugent","year":"1992","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B96","doi-asserted-by":"crossref","first-page":"11164","DOI":"10.1074\/jbc.273.18.11164","article-title":"Inability of the acidic fibroblast growth factor mutant k132e to stimulate DNA synthesis after translocation into cells","volume":"273","author":"Klingenberg","year":"1998","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B97","doi-asserted-by":"crossref","first-page":"18081","DOI":"10.1074\/jbc.274.25.18081","article-title":"Effects of mutations of a phosphorylation site in an exposed loop in acidic fibroblast growth factor","volume":"274","author":"Klingenberg","year":"1999","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B98","doi-asserted-by":"crossref","first-page":"17949","DOI":"10.1074\/jbc.271.30.17949","article-title":"Basic fibroblast growth factor binds its receptors, is internalized, and stimulates DNA synthesis in balb\/c3t3 cells in the absence of heparan sulfate","volume":"271","author":"Fannon","year":"1996","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B99","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1016\/S0021-9258(17)41730-3","article-title":"Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding","volume":"269","author":"Roghani","year":"1994","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B100","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cardiores.2006.01.017","article-title":"Survival kinases in ischemic preconditioning and postconditioning","volume":"70","author":"Hausenloy","year":"2006","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B101","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tcm.2005.03.001","article-title":"The reperfusion injury salvage kinase pathway: A common target for both ischemic preconditioning and postconditioning","volume":"15","author":"Hausenloy","year":"2005","journal-title":"Trends Cardiovasc Med"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B102","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.yjmcc.2009.01.003","article-title":"Multiple protective pathways against reperfusion injury: A safe path without aktion?","volume":"46","author":"Lecour","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B103","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.yjmcc.2009.03.019","article-title":"Activation of the protective survivor activating factor enhancement (safe) pathway against reperfusion injury: Does it go beyond the risk pathway?","volume":"47","author":"Lecour","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B104","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1128\/MCB.11.10.5068","article-title":"A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (flg) is a binding site for the sh2 domain of phospholipase c-gamma 1","volume":"11","author":"Mohammadi","year":"1991","journal-title":"Mol Cell Biol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B105","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1073\/pnas.111114298","article-title":"Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins","volume":"98","author":"Ong","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B106","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1038\/sj.onc.1203650","article-title":"Transformation and stat activation by derivatives of fgfr1, fgfr3, and fgfr4","volume":"19","author":"Hart","year":"2000","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B107","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0092-8674(00)80252-4","article-title":"A lipid-anchored grb2-binding protein that links fgf-receptor activation to the ras\/mapk signaling pathway","volume":"89","author":"Kouhara","year":"1997","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B108","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S1097-2765(05)00087-0","article-title":"Structural basis of snt ptb domain interactions with distinct neurotrophic receptors","volume":"6","author":"Dhalluin","year":"2000","journal-title":"Mol Cell"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B109","doi-asserted-by":"crossref","first-page":"25726","DOI":"10.1074\/jbc.274.36.25726","article-title":"Fibroblast growth factor receptor-1-mediated endothelial cell proliferation is dependent on the src homology (sh) 2\/sh3 domain-containing adaptor protein crk","volume":"274","author":"Larsson","year":"1999","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B110","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.onc.1201936","article-title":"Fibroblast growth factor receptor-1 mediates chemotaxis independently of direct sh2-domain protein binding","volume":"17","author":"Landgren","year":"1998","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B111","first-page":"1475","article-title":"Molecular interactions of the src homology 2 domain protein shb with phosphotyrosine residues, tyrosine kinase receptors and src homology 3 domain proteins","volume":"10","author":"Karlsson","year":"1995","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B112","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1073\/pnas.90.12.5772","article-title":"Raf-1 and p21v-ras cooperate in the activation of mitogen-activated protein kinase","volume":"90","author":"Williams","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B113","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1006\/bbrc.1998.8326","article-title":"Identification of phosphorylated proteins associated with the fibroblast growth factor receptor type i during early xenopus development","volume":"244","author":"Ryan","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B114","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/MCB.16.3.977","article-title":"Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction","volume":"16","author":"Mohammadi","year":"1996","journal-title":"Mol Cell Biol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B115","doi-asserted-by":"crossref","first-page":"23337","DOI":"10.1074\/jbc.270.40.23337","article-title":"Shc and a novel 89-kda component couple to the grb2-sos complex in fibroblast growth factor-2-stimulated cells","volume":"270","author":"Klint","year":"1995","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B116","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1006\/bbrc.1997.7982","article-title":"Novel recruitment of shc, grb2, and sos by fibroblast growth factor receptor-1 in v-src-transformed cells","volume":"243","author":"Curto","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B117","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1124\/mol.115.099630","article-title":"Fulfilling the promise of \u201cbiased\u201d g protein-coupled receptor agonism","volume":"88","author":"Luttrell","year":"2015","journal-title":"Mol Pharmacol"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B118","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1124\/mol.61.4.768","article-title":"Side-chain substitutions within angiotensin ii reveal different requirements for signaling, internalization, and phosphorylation of type 1a angiotensin receptors","volume":"61","author":"Holloway","year":"2002","journal-title":"Mol Pharm"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B119","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0361-9230(01)00623-2","article-title":"Paradoxical trafficking and regulation of 5-ht(2a) receptors by agonists and antagonists","volume":"56","author":"Gray","year":"2001","journal-title":"Brain Res Bull"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B120","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1124\/mol.54.1.94","article-title":"Effector pathway-dependent relative efficacy at serotonin type 2a and 2c receptors: Evidence for agonist-directed trafficking of receptor stimulus","volume":"54","author":"Berg","year":"1998","journal-title":"Mol Pharm"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B121","doi-asserted-by":"crossref","first-page":"13453","DOI":"10.1021\/bi990437n","article-title":"Amino-terminal modifications of human parathyroid hormone (pth) selectively alter phospholipase c signaling via the type 1 pth receptor: Implications for design of signal-specific pth ligands","volume":"38","author":"Takasu","year":"1999","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B122","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1210\/en.2003-1185","article-title":"Ligand-selective dissociation of activation and internalization of the parathyroid hormone (pth) receptor: Conditional efficacy of pth peptide fragments","volume":"145","author":"Sneddon","year":"2004","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B123","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0022-3565(25)12378-1","article-title":"Tachykinin peptides affect differently the second messenger pathways after binding to cho-expressed human nk-1 receptors","volume":"276","author":"Sagan","year":"1996","journal-title":"J Pharm Exp Ther"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B124","doi-asserted-by":"crossref","first-page":"26178","DOI":"10.1074\/jbc.M114.586826","article-title":"Different epidermal growth factor (egf) receptor ligands show distinct kinetics and biased or partial agonism for homodimer and heterodimer formation","volume":"289","author":"Macdonald-Obermann","year":"2014","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180328160631_cvx165-B125","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/nbt.3028","article-title":"Allosteric targeting of receptor tyrosine kinases","volume":"32","author":"De Smet","year":"2014","journal-title":"Nat Biotechnol"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cardiovascres\/article-pdf\/113\/13\/1585\/24254231\/cvx165.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T21:51:21Z","timestamp":1750801881000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/113\/13\/1585\/4107349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,7]]},"references-count":125,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2017,9,7]]},"published-print":{"date-parts":[[2017,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvx165","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,11]]},"published":{"date-parts":[[2017,9,7]]}}}